On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

WASHINGTON, DC—Use of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) appears to be a safe and effective option for the treatment of in-stent restenosis, but acute and late ...

PARIS, May 19, 2015 /PRNewswire/ -- Abbott announced today that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1™, which combines the world's first ...

Two new meta-analyses evaluating the safety and effectiveness of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) suggest the “dissolving” stent is as safe and effective as an ...

Abbott said it will monitor bioabsorbable stent implantations in Europe, following a high rate of heart attacks in European Absorb GT1 patients, plus a separate FDA safety alert regarding adverse ...

Abbott Laboratories, one of the biggest makers of coronary stents in the world, is halting global sales of a fully absorbable stent that was once hailed as the next big breakthrough in medical devices ...

FRESNO, Calif. (KFSN) -- The last time Giacomo Ciabattini walked into Saint Agnes Medical Center in Northeast Fresno, he was in a much bigger hurry. He was having a major cardiac episode on ...

Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new ...

BOSTON (CBS) -- Metal stents are the standard of care for blockages in the heart but a new dissolvable stent was recently approved by the FDA. Dr. Mallika Marshall introduces us to one of the first ...

F or nearly two decades, most patients with blocked heart vessels have been treated with metal stents that open clogged arteries and then remain in place for the individual’s lifetime. But after ...

CHICAGO, IL — Due to low commercial sales, Abbott will stop selling the first-generation bioresorbable Absorb coronary stent, the company announced [1]. Abbott will discontinue all sizes of Absorb ...